An F.D.A. panel recommends a Moderna booster for many Americans.
Source: New York Times
A key advisory committee to the Food and Drug Administration voted on Thursday to recommend a booster shot of the Moderna coronavirus vaccine for many of the vaccine’s recipients, at least six months after a second dose. The panel endorsed a half-dose as a third injection for people 65 and older as well as younger adults at high risk because of their medical conditions or jobs, the same groups of people who became eligible for a Pfizer-BioNTech booster last month.
While regulators are not obligated to follow the panel’s recommendations, they typically do. Committee members said that while they hoped for far more robust data, a number of them said that F.D.A. had already sent a precedent by authorizing booster shots on an emergency basis for many recipients of the Pfizer-BioNTech vaccine. The panel voted after hearing from Moderna officials, agency scientists and a top public health official from Israel, which began offering boosters to Pfizer recipients two and a half months ago.
Dr. Eric Rubin, an adjunct professor of immunology and infectious diseases at the Harvard T. H. Chan School of Public Health, questioned whether Moderna has enough data showing whether a booster shot will create adverse side effects. Like Pfizer, “Moderna is presenting the results of a relatively small trial,” he said. But “Pfizer had all those real-world data from Israel” on its booster campaign, showing results from “millions of people who received the vaccine,” he said.
Johnson & Johnson has asked the Food and Drug Administration to issue emergency use authorization for a booster for recipients of their vaccines, and the panel will vote Friday on the company’s request. They will also hear then about the initial results of an ongoing federal study that found Johnson & Johnson recipients may benefit more from a booster of Moderna’s or Pfizer’s vaccine. The committee will discuss, but not vote on, whether to consider broader eligibility for boosters of both Pfizer and Moderna’s vaccines, allowing people younger than 65 but not at especially high risk to get them.
Read more: https://www.nytimes.com/2021/10/14/us/moderna-boosters-fda.html
Have been watching since they started at 8:30 am EDT. The vote below - unanimous (even with some of them having concerns but I think weighing on some of them was the fact that since Pfizer is approved, it would be a bit of a mess to wait).
EDIT TO NOTE: CDC would still need to give the final "okay".
= new reply since forum marked as read
I still have a week or so to get to 6 months post dose 2 of Moderna but now I can plan to try to get a flu shot and Moderna booster at the same time.
Glad you are next up. 
sometime next week. Since Moderna is sortof in limited circulation around here (most places near me do Pfizer), I would probably try to schedule back at the same pharmacy I had my first doses at (I had checked last month and they offer both - originally only had Moderna). 
